These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37665172)
21. Case report: atypical presentation of mpox with massive hematochezia and prolonged viral shedding despite tecovirimat treatment. Shin SU; Jung Y; Kim SE; Kim DM BMC Infect Dis; 2024 Feb; 24(1):183. PubMed ID: 38342913 [TBL] [Abstract][Full Text] [Related]
22. Absence of association between persistent skin lesion and virological replication in severe disseminated monkeypox infection in solid organ transplant recipient. Rousseau A; Ferrier A; Stabler S; Vuotto F; Massip E; Ouafi M; Cartier N; Ferraris O; Alidjinou EK; Faure E Infect Dis Now; 2023 Sep; 53(6):104749. PubMed ID: 37394180 [TBL] [Abstract][Full Text] [Related]
23. Mpox Genital Lesions: A Large Single-center Experience With Intermediate Follow-up. Lee J; McLean J; Zucker J; Brandes S; Joice G J Urol; 2023 Sep; 210(3):510-516. PubMed ID: 37294043 [TBL] [Abstract][Full Text] [Related]
24. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134 [TBL] [Abstract][Full Text] [Related]
25. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502 [TBL] [Abstract][Full Text] [Related]
26. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report. Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234 [TBL] [Abstract][Full Text] [Related]
27. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques. Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575 [TBL] [Abstract][Full Text] [Related]
28. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox. Suzuki T; Saito S; Tsuzuki S; Ashida S; Takakusaki M; Yoshikawa T; Shimojima M; Ebihara H; Ohmagari N; Morioka S BMJ Open; 2023 Aug; 13(8):e069550. PubMed ID: 37527886 [TBL] [Abstract][Full Text] [Related]
29. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687 [TBL] [Abstract][Full Text] [Related]
30. Non-Healing Corneal Ulcer and Uveitis Following Monkeypox Disease: Diagnostic and Therapeutic Challenges. Androudi S; Kaufman AR; Kouvalakis A; Mitsios A; Sapounas S; Al-Khatib D; Schibler M; Pineda R; Baglivo E Ocul Immunol Inflamm; 2024 Apr; 32(3):253-258. PubMed ID: 37140328 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of tecovirimat in subjects with Mpox. Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A Int J Antimicrob Agents; 2024 Feb; 63(2):107068. PubMed ID: 38141836 [TBL] [Abstract][Full Text] [Related]
32. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Stafford A; Rimmer S; Gilchrist M; Sun K; Davies EP; Waddington CS; Chiu C; Armstrong-James D; Swaine T; Davies F; Gómez CHM; Kumar V; ElHaddad A; Awad Z; Smart C; Mora-Peris B; Muir D; Randell P; Peters J; Chand M; Warrell CE; Rampling T; Cooke G; Dhanji S; Campbell V; Davies C; Osman S; Abbara A Lancet Infect Dis; 2023 Jun; 23(6):e218-e226. PubMed ID: 36773621 [TBL] [Abstract][Full Text] [Related]
33. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. DeLaurentis CE; Kiser J; Zucker J Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026 [TBL] [Abstract][Full Text] [Related]
34. MPox virus: an unusual aetiology of peritonitis. Courdurié A; Buscot M; Gonfrier G; Courjon J; Oncioiu C; Demonchy E; Carles M Sex Transm Infect; 2023 Jun; 99(4):285-286. PubMed ID: 36928093 [TBL] [Abstract][Full Text] [Related]